Research showed that trastuzumab-emtansine(T-DM1) inhibited the growth of uterine and ovarian carcinosarcomas cell lines with human epidermal HER2 overexpression in vivo and in vitro [72]. The gene discussed is ERBB2; the disease is ovarian carcinosarcoma.